Bipolar Radio-frequency Ablation After Standard Unipolar Approach - Prospective Registry.

Recruiting Observational Study
Ventricular Arrythmia
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
100 (estimated)
Sponsor
Centre of Postgraduate Medical Education · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Treatment of ventricular arrhythmias (VA) originating at the base of the heart may be challenging. Unipolar radio-frequency (RF) ablation is a standard approach to treat VA, however, it fails in 10 to 75% of patients, depending on the localization of VA. The main reason for unipolar ablation failure is the intramural location of the source of VA. In such patients, bipolar ablation may occur effect…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Baseline Holter ECG before initial unipolar ablation within 6 months prior to the procedure, performed without antiarrhythmic drugs (beta-blockers allowed). 2. Initial unipolar ablation of VA originating from the base of the heart (R in II, III and aVF) performed according to…
Contacts

Piotr Kulakowski, MD PhD

604455081

piotr.kulakowskimd@gmail.com

CONTACT

Agnieszka Sikorska, MD PhD

604106455

sikorska.agnieszka.anna@gmail.com

CONTACT